-100%

est. 2Y upside i

HealthcareSeries D+

On-demand prescription delivery.

Rank

#3786

Sector

Healthtech

Est. Liquidity

~1Y

Data Quality

Data: Low

This equity is highly risky and likely worthless due to a $74.7M liquidation preference stack that exceeds the company's $19.6M valuation.

Last updated: July 21, 2026

Bull (15%)-100%

Acquisition synergies drive acquirer stock up 20%, but common stock in NimbleRx is worthless due to $74.7M preference stack exceeding any realistic exit value.

Base (55%)-100%

Acquisition closes at ~$19.6M valuation, all proceeds go to preferred holders; common stock receives $0.

Bear (30%)-100%

Downside scenario already captured in base; any exit below $74.7M leaves common stock with 100% loss.

Est. time to liquidity~0.5 years

Preference Stack Risk

severe

Funding Intensity

38060%

Total preferred liquidation preference of $74.7M dwarfs the $19.6M entry valuation, making common stock worthless in any exit below that threshold.

Dilution Risk

low

No further financing expected given the acquisition; dilution is not a concern post-exit.

Secondary Liquidity

none

No secondary market transactions reported; the acquisition is the only liquidity event.

Engineering, Product, Research — 7 roles

Business Development — 3 roles

Success — 3 roles

Marketing — 2 roles

Sales — 2 roles

View all 17 open roles at NimbleRx →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on NimbleRx's data — designed to show you've done your homework.

  • 1

    “How does the acquisition by Swoop change the equity structure and what is the expected common stock recovery in the deal?”

  • 2

    “What is the company's path to profitability given current revenue of $6.1M and total funding of $74.7M?”

  • 3

    “Given the preference stack, what was the implied valuation at the last round and how does the acquisition price compare?”

Community

Valuation Sentiment

Our model estimates -100% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.